Ariceptin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ariceptin, covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery. [Phase 2]